Sentinel lymph node mapping in gynecologic malignancies.
Identifieur interne : 003540 ( PubMed/Curation ); précédent : 003539; suivant : 003541Sentinel lymph node mapping in gynecologic malignancies.
Auteurs : P V Loar [États-Unis] ; R K ReynoldsSource :
- International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [ 0020-7292 ] ; 2007.
Descripteurs français
- KwdFr :
- Animaux, Biopsie de noeud lymphatique sentinelle (), Femelle, Humains, Métastase lymphatique (diagnostic), Pronostic, Tumeurs de l'appareil génital féminin (), Tumeurs de l'appareil génital féminin (anatomopathologie), Tumeurs de l'endomètre (), Tumeurs de l'endomètre (anatomopathologie), Tumeurs de la vulve (), Tumeurs de la vulve (anatomopathologie), Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (anatomopathologie).
- MESH :
- anatomopathologie : Tumeurs de l'appareil génital féminin, Tumeurs de l'endomètre, Tumeurs de la vulve, Tumeurs du col de l'utérus.
- diagnostic : Métastase lymphatique.
- Animaux, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Pronostic, Tumeurs de l'appareil génital féminin, Tumeurs de l'endomètre, Tumeurs de la vulve, Tumeurs du col de l'utérus.
English descriptors
- KwdEn :
- Animals, Endometrial Neoplasms (pathology), Endometrial Neoplasms (therapy), Female, Genital Neoplasms, Female (pathology), Genital Neoplasms, Female (therapy), Humans, Lymphatic Metastasis (diagnosis), Prognosis, Sentinel Lymph Node Biopsy (methods), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (therapy), Vulvar Neoplasms (pathology), Vulvar Neoplasms (therapy).
- MESH :
- diagnosis : Lymphatic Metastasis.
- methods : Sentinel Lymph Node Biopsy.
- pathology : Endometrial Neoplasms, Genital Neoplasms, Female, Uterine Cervical Neoplasms, Vulvar Neoplasms.
- therapy : Endometrial Neoplasms, Genital Neoplasms, Female, Uterine Cervical Neoplasms, Vulvar Neoplasms.
- Animals, Female, Humans, Prognosis.
Abstract
Lymph node status is the most important prognostic factor for women with vulvar, cervical and endometrial carcinoma and complete lymph node dissection has historically been an integral part of the surgical treatment of these diseases. Lymphadenectomy can be morbid for patients, who may experience wound breakdown, lymphocyst formation or chronic lymphedema, among other problems. Sentinel lymph node mapping is a newer technology that allows selective removal of the first node draining a tumor thereby allowing a potentially less aggressive procedure to be performed. Sentinel node mapping is well accepted for the management of breast carcinoma and cutaneous melanoma, and has resulted in reduced morbidity without adversely affecting survival. Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies.
DOI: 10.1016/j.ijgo.2007.06.001
PubMed: 17727856
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003540
Links to Exploration step
pubmed:17727856Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sentinel lymph node mapping in gynecologic malignancies.</title><author><name sortKey="Loar, P V" sort="Loar, P V" uniqKey="Loar P" first="P V" last="Loar">P V Loar</name><affiliation wicri:level="1"><nlm:affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-0276, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-0276</wicri:regionArea></affiliation></author><author><name sortKey="Reynolds, R K" sort="Reynolds, R K" uniqKey="Reynolds R" first="R K" last="Reynolds">R K Reynolds</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17727856</idno><idno type="pmid">17727856</idno><idno type="doi">10.1016/j.ijgo.2007.06.001</idno><idno type="wicri:Area/PubMed/Corpus">003540</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003540</idno><idno type="wicri:Area/PubMed/Curation">003540</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003540</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Sentinel lymph node mapping in gynecologic malignancies.</title><author><name sortKey="Loar, P V" sort="Loar, P V" uniqKey="Loar P" first="P V" last="Loar">P V Loar</name><affiliation wicri:level="1"><nlm:affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-0276, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-0276</wicri:regionArea></affiliation></author><author><name sortKey="Reynolds, R K" sort="Reynolds, R K" uniqKey="Reynolds R" first="R K" last="Reynolds">R K Reynolds</name></author></analytic><series><title level="j">International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</title><idno type="ISSN">0020-7292</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Endometrial Neoplasms (pathology)</term><term>Endometrial Neoplasms (therapy)</term><term>Female</term><term>Genital Neoplasms, Female (pathology)</term><term>Genital Neoplasms, Female (therapy)</term><term>Humans</term><term>Lymphatic Metastasis (diagnosis)</term><term>Prognosis</term><term>Sentinel Lymph Node Biopsy (methods)</term><term>Uterine Cervical Neoplasms (pathology)</term><term>Uterine Cervical Neoplasms (therapy)</term><term>Vulvar Neoplasms (pathology)</term><term>Vulvar Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Biopsie de noeud lymphatique sentinelle ()</term><term>Femelle</term><term>Humains</term><term>Métastase lymphatique (diagnostic)</term><term>Pronostic</term><term>Tumeurs de l'appareil génital féminin ()</term><term>Tumeurs de l'appareil génital féminin (anatomopathologie)</term><term>Tumeurs de l'endomètre ()</term><term>Tumeurs de l'endomètre (anatomopathologie)</term><term>Tumeurs de la vulve ()</term><term>Tumeurs de la vulve (anatomopathologie)</term><term>Tumeurs du col de l'utérus ()</term><term>Tumeurs du col de l'utérus (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs de l'appareil génital féminin</term><term>Tumeurs de l'endomètre</term><term>Tumeurs de la vulve</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphatic Metastasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Métastase lymphatique</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Endometrial Neoplasms</term><term>Genital Neoplasms, Female</term><term>Uterine Cervical Neoplasms</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Endometrial Neoplasms</term><term>Genital Neoplasms, Female</term><term>Uterine Cervical Neoplasms</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Female</term><term>Humans</term><term>Prognosis</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Pronostic</term><term>Tumeurs de l'appareil génital féminin</term><term>Tumeurs de l'endomètre</term><term>Tumeurs de la vulve</term><term>Tumeurs du col de l'utérus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymph node status is the most important prognostic factor for women with vulvar, cervical and endometrial carcinoma and complete lymph node dissection has historically been an integral part of the surgical treatment of these diseases. Lymphadenectomy can be morbid for patients, who may experience wound breakdown, lymphocyst formation or chronic lymphedema, among other problems. Sentinel lymph node mapping is a newer technology that allows selective removal of the first node draining a tumor thereby allowing a potentially less aggressive procedure to be performed. Sentinel node mapping is well accepted for the management of breast carcinoma and cutaneous melanoma, and has resulted in reduced morbidity without adversely affecting survival. Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17727856</PMID><DateCreated><Year>2007</Year><Month>09</Month><Day>10</Day></DateCreated><DateCompleted><Year>2008</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0020-7292</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</Title><ISOAbbreviation>Int J Gynaecol Obstet</ISOAbbreviation></Journal><ArticleTitle>Sentinel lymph node mapping in gynecologic malignancies.</ArticleTitle><Pagination><MedlinePgn>69-74</MedlinePgn></Pagination><Abstract><AbstractText>Lymph node status is the most important prognostic factor for women with vulvar, cervical and endometrial carcinoma and complete lymph node dissection has historically been an integral part of the surgical treatment of these diseases. Lymphadenectomy can be morbid for patients, who may experience wound breakdown, lymphocyst formation or chronic lymphedema, among other problems. Sentinel lymph node mapping is a newer technology that allows selective removal of the first node draining a tumor thereby allowing a potentially less aggressive procedure to be performed. Sentinel node mapping is well accepted for the management of breast carcinoma and cutaneous melanoma, and has resulted in reduced morbidity without adversely affecting survival. Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loar</LastName><ForeName>P V</ForeName><Initials>PV</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-0276, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>R K</ForeName><Initials>RK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynaecol Obstet</MedlineTA><NlmUniqueID>0210174</NlmUniqueID><ISSNLinking>0020-7292</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014846" MajorTopicYN="N">Vulvar Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17727856</ArticleId><ArticleId IdType="pii">S0020-7292(07)00316-5</ArticleId><ArticleId IdType="doi">10.1016/j.ijgo.2007.06.001</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003540 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003540 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:17727856
|texte= Sentinel lymph node mapping in gynecologic malignancies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:17727856" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |